Literature DB >> 28442794

Innate and adaptive immunity shape circulating HCV strains.

Silvana Gaudieri1, Michaela Lucas2.   

Abstract

An unbiased genome-to-genome analysis in chronic hepatitis C virus (HCV) infection confirms the innate and adaptive arms of the immune system as drivers of viral evolution. Viral adaptation has a critical role in the interaction between host and pathogen and has important clinical implications for infection outcome.

Entities:  

Mesh：

Year:  2017        PMID： 28442794     DOI： 10.1038/ng.3856

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


  14 in total

1.  Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.

Authors:  Corey B Moore; Mina John; Ian R James; Frank T Christiansen; Campbell S Witt; Simon A Mallal
Journal:  Science       Date:  2002-05-24       Impact factor: 47.728

2.  Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection.

Authors:  Silvana Gaudieri; Andri Rauch; Lawrence P Park; Elizabeth Freitas; Susan Herrmann; Gary Jeffrey; Wendy Cheng; Katja Pfafferott; Kiloshni Naidoo; Russell Chapman; Manuel Battegay; Rainer Weber; Amalio Telenti; Hansjakob Furrer; Ian James; Michaela Lucas; Simon A Mallal
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

3.  Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.

Authors:  Andri Rauch; Zoltán Kutalik; Patrick Descombes; Tao Cai; Julia Di Iulio; Tobias Mueller; Murielle Bochud; Manuel Battegay; Enos Bernasconi; Jan Borovicka; Sara Colombo; Andreas Cerny; Jean-François Dufour; Hansjakob Furrer; Huldrych F Günthard; Markus Heim; Bernard Hirschel; Raffaele Malinverni; Darius Moradpour; Beat Müllhaupt; Andrea Witteck; Jacques S Beckmann; Thomas Berg; Sven Bergmann; Francesco Negro; Amalio Telenti; Pierre-Yves Bochud
Journal:  Gastroenterology       Date:  2010-01-11       Impact factor: 22.682

4.  IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study.

Authors:  Vijayaprakash Suppiah; Silvana Gaudieri; Nicola J Armstrong; Kate S O'Connor; Thomas Berg; Martin Weltman; Maria Lorena Abate; Ulrich Spengler; Margaret Bassendine; Gregory J Dore; William L Irving; Elizabeth Powell; Margaret Hellard; Stephen Riordan; Gail Matthews; David Sheridan; Jacob Nattermann; Antonina Smedile; Tobias Müller; Emma Hammond; David Dunn; Francesco Negro; Pierre-Yves Bochud; Simon Mallal; Golo Ahlenstiel; Graeme J Stewart; Jacob George; David R Booth
Journal:  PLoS Med       Date:  2011-09-13       Impact factor: 11.069

5.  HIV-1 adaptation to NK-cell-mediated immune pressure.

Authors:  Galit Alter; David Heckerman; Arne Schneidewind; Lena Fadda; Carl M Kadie; Jonathan M Carlson; Cesar Oniangue-Ndza; Maureen Martin; Bin Li; Salim I Khakoo; Mary Carrington; Todd M Allen; Marcus Altfeld
Journal:  Nature       Date:  2011-08-03       Impact factor: 49.962

6.  Divergent and convergent evolution after a common-source outbreak of hepatitis C virus.

Authors:  Stuart C Ray; Liam Fanning; Xiao-Hong Wang; Dale M Netski; Elizabeth Kenny-Walsh; David L Thomas
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

7.  A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control.

Authors:  István Bartha; Jonathan M Carlson; Chanson J Brumme; Paul J McLaren; Zabrina L Brumme; Mina John; David W Haas; Javier Martinez-Picado; Judith Dalmau; Cecilio López-Galíndez; Concepción Casado; Andri Rauch; Huldrych F Günthard; Enos Bernasconi; Pietro Vernazza; Thomas Klimkait; Sabine Yerly; Stephen J O'Brien; Jennifer Listgarten; Nico Pfeifer; Christoph Lippert; Nicolo Fusi; Zoltán Kutalik; Todd M Allen; Viktor Müller; P Richard Harrigan; David Heckerman; Amalio Telenti; Jacques Fellay
Journal:  Elife       Date:  2013-10-29       Impact factor: 8.140

8.  Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.

Authors:  Karen Fitzmaurice; Jacob Hurst; Megan Dring; Andri Rauch; Paul J McLaren; Huldrych F Günthard; Clair Gardiner; Paul Klenerman
Journal:  Gut       Date:  2014-07-04       Impact factor: 23.059

9.  HLA Class-II Associated HIV Polymorphisms Predict Escape from CD4+ T Cell Responses.

Authors:  Nathan Erdmann; Victor Y Du; Jonathan Carlson; Malinda Schaefer; Alexander Jureka; Sarah Sterrett; Ling Yue; Dario Dilernia; Shabir Lakhi; Jianming Tang; John Sidney; Jill Gilmour; Susan Allen; Eric Hunter; Sonya Heath; Anju Bansal; Paul A Goepfert
Journal:  PLoS Pathog       Date:  2015-08-24       Impact factor: 6.823

10.  The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design.

Authors:  Annette von Delft; Isla S Humphreys; Anthony Brown; Katja Pfafferott; Michaela Lucas; Paul Klenerman; Georg M Lauer; Andrea L Cox; Silvana Gaudieri; Eleanor Barnes
Journal:  Gut       Date:  2015-06-19       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.